The regional mortality trend in Russia in 2016–2019 and its comparison with that in 2020; the contribution of COVID-19

DOI: https://doi.org/10.29296/25877305-2022-03-01
Issue: 
3
Year: 
2022

Professor I. Samorodskaya, MD National Medical Research Center for Therapy and Preventive
Medicine, Ministry of Health of Russia, Moscow

Objective. To study the trend of regional mortality rates for all causes and three groups of causes (diseases, external causes, alcohol, and drug abuse) in 2016-2019, to compare 4-year average mortality rates since 2020 and to evaluate the contribution of COVID-19 to disease mortality rates. Material and methods. The Russian Federal State Statistics Service data on the average annual population size and the number of deaths in one-year age groups for 2016–2020 were analyzed. Standardized death rates (SDRs) for all causes, three causes (diseases, external causes, alcohol, and drug abuse), average regional SDRs, and standard deviation were determined. Results. The average regional SDRs for all causes decreased from 2016 to 2019, but an annual decrease was recorded in SDR only in half of the regions; the trends were undulating. In 2020 versus 2016–2019, SDR showed an average increase by 12.9±5.3% (p
Keywords: 
mortality
causes of death
regions of the Russian Federation

References: 
  1. Samorodskaja I.V. Kodirovanie prichin smerti kak faktor, vlijajuschij na pokazateli smertnosti naselenija ot otdel'nyh prichin. Vrach. 2021; 32 (5): 21–7. DOI: 10.29296/25877305-2021-05-04
  2. Drapkina O.M., Samorodskaja I.V., Semenov V.Ju. i dr. Sravnitel'nyj analiz variabel'nosti pokazatelej smertnosti ot razlichnyh prichin v sub'ektah Rossijskoj Federatsii. Arhiv patologii. 2020; 82 (3): 31–7. DOI: 10.17116/patol20208203131
  3. Drapkina O.M., Samorodskaja I.V., Kakorina E.P. i dr. Metody i problemy nozologicheskogo analiza smertnosti v period pandemii COVID-19. Natsional'noe zdravoohranenie. 2021; 2 (1): 51–8. DOI: 10.47093/2713-069X.2021.2.1.51-58
  4. Drapkina O.M., Samorodskaja I.V., Kakorina E.P. i dr. COVID-19 i regional'naja smertnost' v Rossijskoj Federatsii. Profilakticheskaja meditsina. 2021; 24 (7): 14–21. DOI: 10.17116/profmed20212407114
  5. Baud D., Qi X., Nielsen-Saines K. et al. Real estimates of mortality following COVID-19 infection. Lancet Infect Dis. 2020; 20 (7):773. DOI: 10.1016/S1473-3099(20)30195-X
  6. Rizzo M., Foresti L., Montano N. Comparison of Reported Deaths From COVID-19 and Increase in Total Mortality in Italy. JAMA Intern Med. 2020; 180 (9): 1250–2. DOI: 10.1001/jamainternmed.2020.2543
  7. Gudima G.O., Haitov R.M., Kudlaj D.A. i dr. Molekuljarno-immunologicheskie aspekty diagnostiki, profilaktiki i lechenija koronavirusnoj infektsii. Immunologija. 2021; 42 (3): 198–210. DOI: 10.33029/0206-4952-2021-42-3-198-210
  8. Tret'jakov V.V., Samorodskaja I.V., Bojtsov S.A. Analiz pokazatelej smertnosti v gruppah regionov s raznym urovnem sotsial'no-ekonomicheskogo razvitija. Menedzher zdravoohranenija. 2016; 7: 46–56.
  9. Excess mortality during the Coronavirus pandemic (COVID-19). URL: https://ourworldindata.org/excess-mortality-covid
  10. Weinberger D.M., Chen J., Cohen T. et al. Estimation of Excess Deaths Associated With the COVID-19 Pandemic in the United States, March to May 2020. JAMA Intern Med. 2020; 180 (10): 1336–44. DOI: 10.1001/jamainternmed.2020.3391
  11. Oliver D. Mistruths and misunderstandings about COVID-19 death numbers. BMJ. 2021; 372: n352. DOI: 10.1136/bmj.n352 pmid:33568449
  12. WHO. Coronavirus disease (COVID-19) Pandemic. Geneva: WHO. 2020. URL: https://www.who.int/emergencies/diseases/novel-coronavirus-2019
  13. Islam N. “Excess deaths” is the best metric for tracking the pandemic. BMJ. 2022; 376: o285. DOI: 10.1136/bmj.o285
  14. Dongshan Zhu, Akihiko Ozaki, Salim S. Virani. Disease-Specific Excess Mortality During the COVID-19 Pandemic: An Analysis of Weekly US Death Data for 2020. Am J Public Health. 2021; 111 (8): 1518–22. DOI: 10.2105/AJPH.2021.306315
  15. Hennessee I., Clennon J.A., Waller L.A. et al. Considerations for Improving Reporting and Analysis of Date-Based COVID-19 Surveillance Data by Public Health Agencies. Am J Public Health. 2021; 111 (12): 2127–32. DOI: 10.2105/AJPH.2021.306520
  16. Hasan M.N., Haider N., Stigler F.L. et al. The Global Case-Fatality Rate of COVID-19 Has Been Declining Since May 2020. Am J Trop Med Hyg. 2021; 104 (6): 2176–84. DOI: 10.4269/ajtmh.20-1496
  17. Faust J.S., Krumholz H.M., Du C. et al. All-Cause Excess Mortality and COVID-19–Related Mortality Among US Adults Aged 25–44 Years, March-July 2020. JAMA. 2021; 325 (8): 785–7. DOI: 10.1001/jama.2020.24243
  18. Kirillov Y., Timofeev S., Avdalyan A. et al. Analysis of Risk Factors in COVID-19 Adult Mortality in Russia. J Prim Care Community Health. 2021; 12: 21501327211008050. DOI: 10.1177/21501327211008050
  19. Drapkina O.M., Karpov O.E., Luk'janov M.M. i dr. Opyt sozdanija i pervye rezul'taty prospektivnogo gospital'nogo registra patsientov s predpolagaemymi ili podtverzhdennymi koronavirusnoj infektsiej (COVID-19) i vnebol'nichnoj pnevmoniej (TARGET-VIP). Profilakticheskaja meditsina. 2020; 23 (8): 6–13. DOI: 10.17116/profmed2020230816
  20. Wu J., Mamas M.A., Mohamed M.O. et al. Place and causes of acute cardiovascular mortality during the COVID-19 pandemic. Heart. 2021; 107 (2): 113–9. DOI: 10.1136/heartjnl-2020-317912
  21. Chan N., Eikelboom J. Hypercoagulability and thrombosis in COVID-19: a modifiable cause for mortality? Eur Heart J. 2021; 42 (33): 3143–5. DOI: 10.1093/eurheartj/ehab417
  22. Samorodskaja I.V. Dokazatel'naja i eksperimental'naja terapija COVID-19. URL: https://medvestnik.ru/content/medarticles/Dokazatelnaya-i-eksperimentalnaya-terapiya-COVID-19.html
  23. Maslove D.M., Sibley S., Boyd J.G. et al. Complications of critical COVID-19: Diagnostic and therapeutic considerations for the mechanically ventilated patient. Chest. 2021: S0012-3692(21)04094-0. DOI: 10.1016/j.chest.2021.10.011
  24. French G., Hulse M., Nguyen D. et al. Impact of Hospital Strain on Excess Deaths During the COVID-19 Pandemic – United States, July 2020–July 2021. MMWR Morb Mortal Wkly Rep. 2021; 70: 1613–6. DOI: 10.15585/mmwr.mm7046a5
  25. Chin M.H. Uncomfortable Truths - What Covid-19 Has Revealed about Chronic-Disease Care in America. N Engl J Med. 2021; 385 (18): 1633–6. DOI: 10.1056/NEJMp2112063
  26. Aktual'naja epidemicheskaja situatsija v Rossii i mire. Federal'naja sluzhba po nadzoru v sfere zaschity prav potrebitelej i blagopoluchija cheloveka. URL: https://www.rospotrebnadzor.ru/region/korono_virus/epid.php
  27. Samorodskaya I. Cause-of-death coding as a factor influencing mortality rates from individual causes. Vrach. 2021; 32 (5): 21–27 (in Russ.). DOI: 10.29296/25877305-2021-05-04
  28. Drapkina O.M., Samorodskaia I.V., Semenov V.Yu. et al. Comparative analysis of variability of mortality rates from various causes in the subjects of Russian Federation. Arkhiv Patologii. 2020; 82 (3): 31–7 (in Russ.). DOI: 10.17116/patol20208203131
  29. Drapkina O.M., Samorodskaya I.V., Kakorina E.P. et al. Methods and problems of the nosological analysis of mortality in the period of COVID-19 pandemic. National Health Care (Russia). 2021; 2 (1): 51–8 (in Russ.). DOI: 10.47093/2713-069X.2021.2.1.51-58
  30. Drapkina O.M., Samorodskaya I.V., Kakorina E.P. et al. COVID-19 and regional mortality in the Russian Federation. Profilakticheskaya Meditsina. 2021; 24 (7): 14–21 (in Russ.). DOI: 10.17116/profmed20212407114
  31. Baud D., Qi X., Nielsen-Saines K. et al. Real estimates of mortality following COVID-19 infection. Lancet Infect Dis. 2020; 20 (7):773. DOI: 10.1016/S1473-3099(20)30195-X
  32. Rizzo M., Foresti L., Montano N. Comparison of Reported Deaths From COVID-19 and Increase in Total Mortality in Italy. JAMA Intern Med. 2020; 180 (9): 1250–2. DOI: 10.1001/jamainternmed.2020.2543
  33. Gudima G.O., Khaitov R.M., Kudlay D.A. et al. Molecular immunological aspects of diagnostics, prevention and treatment of coronavirus infection. Immunologiya. 2021; 42 (3): 198–210 (in Russ.) DOI: 10.33029/0206-4952-2021-42-3-198-210
  34. Tret’yakov V.V., Samorodskaya I.V., Boytsov S.A. Analysis of mortality rates in the groups of regions with different levels of socio-economic development. Menedzher zdravookhraneniya. 2016; 7: 46–56 (in Russ.).
  35. Excess mortality during the Coronavirus pandemic (COVID-19). URL: https://ourworldindata.org/excess-mortality-covid
  36. Weinberger D.M., Chen J., Cohen T. et al. Estimation of Excess Deaths Associated With the COVID-19 Pandemic in the United States, March to May 2020. JAMA Intern Med. 2020; 180 (10): 1336–44. DOI: 10.1001/jamainternmed.2020.3391
  37. Oliver D. Mistruths and misunderstandings about COVID-19 death numbers. BMJ. 2021; 372: n352. DOI: 10.1136/bmj.n352 pmid:33568449
  38. WHO. Coronavirus disease (COVID-19) Pandemic. Geneva: WHO. 2020. URL: https://www.who.int/emergencies/diseases/novel-coronavirus-2019
  39. Islam N. “Excess deaths” is the best metric for tracking the pandemic. BMJ. 2022; 376: o285. DOI: 10.1136/bmj.o285
  40. Dongshan Zhu, Akihiko Ozaki, Salim S. Virani. Disease-Specific Excess Mortality During the COVID-19 Pandemic: An Analysis of Weekly US Death Data for 2020. Am J Public Health. 2021; 111 (8): 1518–22. DOI: 10.2105/AJPH.2021.306315
  41. Hennessee I., Clennon J.A., Waller L.A. et al. Considerations for Improving Reporting and Analysis of Date-Based COVID-19 Surveillance Data by Public Health Agencies. Am J Public Health. 2021; 111 (12): 2127–32. DOI: 10.2105/AJPH.2021.306520
  42. Hasan M.N., Haider N., Stigler F.L. et al. The Global Case-Fatality Rate of COVID-19 Has Been Declining Since May 2020. Am J Trop Med Hyg. 2021; 104 (6): 2176–84. DOI: 10.4269/ajtmh.20-1496
  43. Faust J.S., Krumholz H.M., Du C. et al. All-Cause Excess Mortality and COVID-19–Related Mortality Among US Adults Aged 25–44 Years, March-July 2020. JAMA. 2021; 325 (8): 785–7. DOI: 10.1001/jama.2020.24243
  44. Kirillov Y., Timofeev S., Avdalyan A. et al. Analysis of Risk Factors in COVID-19 Adult Mortality in Russia. J Prim Care Community Health. 2021; 12: 21501327211008050. DOI: 10.1177/21501327211008050
  45. Drapkina O.M., Karpov O.E., Loukyanov M.M. et al. Experience of creating and the first results of the prospective hospital registry of patients with suspected or confirmed coronavirus infection (COVID-19) and community-acquired pneumonia (TARGET-VIP). Profilakticheskaya Meditsina. 2020; 23 (8): 6–13 (in Russ.). DOI: 10.17116/profmed2020230816
  46. Wu J., Mamas M.A., Mohamed M.O. et al. Place and causes of acute cardiovascular mortality during the COVID-19 pandemic. Heart. 2021; 107 (2): 113–9. DOI: 10.1136/heartjnl-2020-317912
  47. Chan N., Eikelboom J. Hypercoagulability and thrombosis in COVID-19: a modifiable cause for mortality? Eur Heart J. 2021; 42 (33): 3143–5. DOI: 10.1093/eurheartj/ehab417
  48. Samorodskaya I.V. Dokazatel’naya i eksperimental’naya terapiya COVID-19 (in Russ.). URL: https://medvestnik.ru/content/medarticles/Dokazatelnaya-i-eksperimentalnaya-terapiya-COVID-19.html
  49. Maslove D.M., Sibley S., Boyd J.G. et al. Complications of critical COVID-19: Diagnostic and therapeutic considerations for the mechanically ventilated patient. Chest. 2021: S0012-3692(21)04094-0. DOI: 10.1016/j.chest.2021.10.011
  50. French G., Hulse M., Nguyen D. et al. Impact of Hospital Strain on Excess Deaths During the COVID-19 Pandemic – United States, July 2020–July 2021. MMWR Morb Mortal Wkly Rep. 2021; 70: 1613–6. DOI: 10.15585/mmwr.mm7046a5
  51. Chin M.H. Uncomfortable Truths - What Covid-19 Has Revealed about Chronic-Disease Care in America. N Engl J Med. 2021; 385 (18): 1633–6. DOI: 10.1056/NEJMp2112063
  52. Aktual’naya epidemicheskaya situatsiya v Rossii i mire. Federal’’naya sluzhba po nadzoru v sfere zashchity prav potrebitelei i blagopoluchiya cheloveka (in Russ.). URL: https://www.rospotrebnadzor.ru/region/korono_virus/epid.php